Ductal carcinoma in-situ arising in mammary-like glands of the vulva.
Castro CY, Deavers M.
Int J Gynecol Pathol. 2001 Jul;20(3):277-83. doi: 10.1097/00004347-200107000-00012.
Topical 5-fluorouracil in the treatment of carcinoma in situ of the vulva.
Carson TE, Hoskins WJ, Wurzel JF.
Obstet Gynecol. 1976 Jan;47(1):59S-62S.
HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva.
Parra-Herran C, Nucci MR, Singh N, Rakislova N, Howitt BE, Hoang L, Gilks CB, Bosse T, Watkins JC.
Mod Pathol. 2022 Oct;35(10):1317-1326. doi: 10.1038/s41379-022-01079-7. Epub 2022 Apr 18.
Cancer of the Vulva: A Review.
Michalski BM, Pfeifer JD, Mutch D, Council ML.
Dermatol Surg. 2021 Feb 1;47(2):174-183. doi: 10.1097/DSS.0000000000002584.
Carcinoma in situ of the vulva.
Woodruff JD.
Clin Obstet Gynecol. 1991 Sep;34(3):669-76.
Vulvar ductal carcinoma in situ as a manifestation of ectopic breast tissue.
Sandak MD, Chandler KA, Goberdhan SP, Willett WF, Scarborough CS.
Int J Gynaecol Obstet. 2023 Feb;160(2):707-708. doi: 10.1002/ijgo.14474. Epub 2022 Oct 5.
Management of carcinoma in situ of the vulva.
Forney JP, Morrow CP, Townsend DE, DiSaia PJ.
Am J Obstet Gynecol. 1977 Apr 15;127(8):801-6. doi: 10.1016/0002-9378(77)90108-9.
Carcinoma in situ of the vulva.
WOODRUFF JD, HILDEBRANDT EE.
Obstet Gynecol. 1958 Oct;12(4):414-24.
Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach.
Yang H, Almadani N, Thompson EF, Tessier-Cloutier B, Chen J, Ho J, Senz J, McConechy MK, Chow C, Ta M, Cheng A, Karnezis A, Huvila J, McAlpine JN, Gilks B, Jamieson A, Hoang LN.
Mod Pathol. 2023 Jun;36(6):100145. doi: 10.1016/j.modpat.2023.100145. Epub 2023 Feb 22.
Treatment of carcinoma in situ of the vulva with topical 5-fluorouracil.
Lifshitz S, Roberts JA.
Obstet Gynecol. 1980 Aug;56(2):242-4.
